相关实验视频
Updated: Jan 13, 2026

07:47
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
16.0K
延迟折扣与抑郁相关,但不能预测抗抑郁药物停用后的复发
Doron Elad1, Giles W Story2,3,4, Isabel M Berwian5
1Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Molecular psychiatry
|January 8, 2026
概括
通过延迟折扣测量的大型抑郁症 (MDD) 失耐症在接受抗抑郁药物治疗 (ADM) 的人中较高. 然而,这种不耐烦并不能预测停止ADM后的复发.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 行为经济学是一种行为经济学.
背景情况:
- 大型抑郁症 (MDD) 复发在停止服用抗抑郁药物 (ADM) 后很常见.
- 需要复发的预测因素.
- 延迟折扣,是一种不耐烦的度量,与MDD有关,可以预测复发.
研究的目的:
- 调查延迟折扣是否预测在停止服用抗抑郁药物 (ADM) 后患有重大抑郁障碍 (MDD) 患者的复发.
- 为了比较缓解MDD患者和对照人群之间的延迟折扣.
- 检查ADM停止后延迟折扣的变化.
主要方法:
- 测量缓解MDD患者 (N=97) 和对照组 (N=54) 的延迟折扣的多站点研究.
- 在MDD组中,在停止使用ADM之前和在停止使用ADM后六个月内进行的测量.
- 用于评估基线折扣和预测半年内复发的早期变化的预测模型.
主要成果:
- 缓解后的MDD患者的基线延迟折扣显著高于对照组 (p < 0.05).
- 基线延迟折扣与抑郁症严重程度正相关 (斯皮尔曼 ρ = 0.24).
- 延迟折扣在停用ADM后没有增加,也没有预测复发.
结论:
- 延迟折扣在治疗ADM的缓解MDD患者中升高.
- 延迟折扣在ADM停止后不会发生变化.
- 延迟折扣不是一个可靠的预测,在MDD中复发的ADM停止后.
相关概念视频
Depressive Disorders: MDD and Dysthymia
618
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
618
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Depressive Disorders: Etiology
433
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
433
Depression: Overview
768
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
768
Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797

